Sun 5/19/2013 18:48 ET
DJIA15354.40122.840.80%SOLAR23.631.245.26%GOLD1356.3030.602.21%Shanghai2282.8731.501.38%
S&P 5001667.4717.171.03%BANKS19.950.261.32%OIL96.030.870.91%Nikkei15138.12101.430.67%
NASDAQ3498.9733.940.97%SEMI38.770.431.12%US/EU0.780.000.39%Futures1662.400.600.04%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Immunomedics - IMMU   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IMMU
  
From: Rambler (Rep: 204)Date: 01/21/2011 10:03
Forum: Immunomedics - Msg #668Thread #673148310 (Rec: 0)
10:00 IMMU Immunomedics reports targeted therapy for advanced pancreatic cancer improves survival (3.46 +0.10) Co announced that repeated therapy cycles of its proprietary antibody, clivatuzumab tetraxetan, labeled with yttrium-90 (Y-90) plus low-dose gemcitabine at 200 mg/m2, extended median overall survival (OS) to 11.8 months, more than double the 5.4 months OS in patients treated with a single cycle. Increased Y-90 doses also improved responses; patients receiving a dose of 12 mCi/m2 or



Share This Post:


My Enzo & 599GTB http://www.flickr.com/photos/30532649@N02/sets/72157613596261365/

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Rambler: Reward | Watch | IgnoreIMMU: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IMMU
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.